Evidence map›Paper›PMID 25192978›Full record

ArticleThe Journal of membrane biology2014

Nanoparticle surface-enhanced Raman scattering of bacteriorhodopsin stabilized by amphipol A8-35.

V Polovinkin, T Balandin, O Volkov, E Round, V Borshchevskiy, P Utrobin, D von Stetten, A Royant, D Willbold, G Arzumanyan and 3 more

Abstract read
PubMed Publisher
In one paragraph

Article in The Journal of membrane biology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 8 citations in OpenAlex.

  1. Amphipols for each season.The Journal of membrane biology · 2014
    Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 7 institutions in 3 countries.

V PolovinkinUniv. Grenoble Alpes, IBS, 38044, Grenoble, France.
T Balandin
O Volkov
E Round
V Borshchevskiy
P Utrobin
D von Stetten
A Royant
D Willbold
G Arzumanyan
V Chupin
J-L Popot
V Gordeliy
Forschungszentrum Jülich · DEMoscow Institute of Physics and Technology · RUInstitut de Biologie Structurale · FRCEA Grenoble · FRCentre National de la Recherche Scientifique · FREuropean Synchrotron Radiation Facility · FRJoint Institute for Nuclear Research · RU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Surface-enhanced Raman spectroscopy (SERS) has developed dramatically since its discovery in the 1970s, because of its power as an analytical tool for selective sensing of molecules adsorbed onto noble metal nanoparticles (NPs) and nanostructures, including at the single-molecule (SM) level. Despite the high importance of membrane proteins (MPs), SERS application to MPs has not really been studied, due to the great handling difficulties resulting from the amphiphilic nature of MPs. The ability of amphipols (APols) to trap MPs and keep them soluble, stable, and functional opens up onto highly interesting applications for SERS studies, possibly at the SM level. This seems to be feasible since single APol-trapped MPs can fit into gaps between noble metal NPs, or in other gap-containing SERS substrates, whereby the enhancement of Raman scattering signal may be sufficient for SM sensitivity. The goal of the present study is to give a proof of concept of SERS with APol-stabilized MPs, using bacteriorhodopsin (BR) as a model. BR trapped by APol A8-35 remains functional even after partial drying at a low humidity. A dried mixture of silver Lee-Meisel colloid NPs and BR/A8-35 complexes give rise to SERS with an average enhancement factor in excess of 10(2). SERS spectra resemble non-SERS spectra of a dried sample of BR/APol complexes.

Indexed as

BacteriorhodopsinsFeasibility StudiesHydrophobic and Hydrophilic InteractionsMetal NanoparticlesPolymersPropylaminesSilverSolubilitySpectrum Analysis, RamanSurface-Active Agentsamphipol A8-35BacteriorhodopsinsPolymersPropylaminesSilverSurface-Active Agents

Identifiers

PMID25192978
OpenAlexW2149213189

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.